Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Haberey Martin is active.

Publication


Featured researches published by Haberey Martin.


Archive | 2003

New substituted N-(1,4,5,6-tetrahydro-cyclopentapyrazol-3-yl) derivatives, useful as cyclin-dependent kinase inhibitors for treating e.g. cancer, autoimmune diseases, cardiovascular diseases and neurodegenerative diseases

Krueger Martin; Prien Olaf; Steinmeyer Andreas; Kroll Joerg; Ernst Alexander; Siemeister Gerhard; Haberey Martin; Hoffmann Jens


Archive | 2001

Ortho substituierte anthranilsäureamide und deren verwendung als arzneimittel

Krueger Martin; Huth Andreas; Petrov Orlin; Seidelmann Dieter; Thierauch Karl-Heinz; Haberey Martin; Menrad Andreas; Ernst Alexander


Archive | 1985

20-ALKYL-7-OXOPROSTACYCLINE DERIVATIVES AND PRODUCTION PROCESS THEREOF

Nickolson Robert; Vorbrueggen Helmut; Stuerzebecher Claus-Steffen; Haberey Martin


Archive | 1996

22-En-25-oxa-Derivate in der Vitamin D-Reihe, Verfahren zu ihrer Herstellung, diese Derivate enthaltenen pharmazeutische Präparate sowie deren Verwendung als Arzneimittel

Neef Guenter; Steinmeyer Andreas; Kirsch Gerald; Schwarz Katica; Haberey Martin; Thieroff-Ekerdt Ruth; Rach Petra


Archive | 2002

New heterocyclylmethyl-substituted anthranilamide derivatives and analogs as KDR/FLT tyrosine kinase inhibitors, used for treating e.g. psoriasis, restenosis, leukemia, arthritis, eye or kidney disease or arteriosclerosis

Huth Andreas; Krueger Martin; Ernst Alexander; Thierauch Karl-Heinz; Haberey Martin; Menrad Andreas


Archive | 2001

New cyanoanthranylamide derivatives, useful for treating e.g. psoriasis and Kaposi sarcoma, are inhibitors of angiogenesis, acting selectively on specific tyrosine kinases

Huth Andreas; Krueger Martin; Thierauch Karl-Heinz; Ernst Alexander; Menrad Andreas; Haberey Martin


Archive | 2000

Neue vitamin d-derivate mit cyclischen substrukturen in den seitenketten, verfahren und zwischenprodukte zu ihrer herstellung und die verwendung zur herstellung von arzneimitteln

Steinmeyer Andreas; Schwarz Katica; Giessen Claudia; Haberey Martin; Faehnrich Marianne


Archive | 2013

ΣΥΝΔΥΑΣΜΟΙ ΚΑΙ ΣΥΝΘΕΣΕΙΣ ΠΟΥ ΠΑΡΕΜΠΟΔΙΖΟΥΝ ΤΗ ΛΕΙΤΟΥΡΓΙΑ ΥΠΟΔΟΧΕΑ VEGF/VEGF ΚΑΙ ΑΓΓΕΙΟΠΟΙΗΤΙΝΗΣ/TIE ΚΑΙ Η ΧΡΗΣΗ ΤΟΥΣ (ΙΙ)

Siemeister Gerhard; Haberey Martin; Thierauch Karl-Heinz


Archive | 2013

Piridinureas de nicotinamida como inhibidores de la cinasa del receptor del factor de crecimiento endotelial vascular (VEGF)

Bohlmann Rolf; Haberey Martin; Hess-Stumpp Holger; Huth Andreas; Ince Stuart; Krueger Martin; Thierauch Karl-Heinz


Archive | 2010

N-aryl(thio)anthranilic acid amide derivatives, pharmaceutical composition containing them, their preparation and their use as VEGF receptor tyrosine kinase inhibitors

Altmann Karl-Heinz; Bold Guido; Furet Pascal; Manley Paul William; Wood Jeanette Marjorie; Ferrari Stefano; Hofmann Francesco; Mestan Juergen; Huth Andreas; Krueger Martin; Seidelmann Dieter; Menrad Andreas; Haberey Martin; Thierauch Karl-Heinz

Collaboration


Dive into the Haberey Martin's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge